A detailed history of Capital Advisors, Ltd. LLC transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 48 shares of CSBR stock, worth $528. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48
Holding current value
$528
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$3.79 - $8.62 $181 - $413
48 New
48 $0

Others Institutions Holding CSBR

About CHAMPIONS ONCOLOGY, INC.


  • Ticker CSBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,522,400
  • Market Cap $149M
  • Description
  • Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...
More about CSBR
Track This Portfolio

Track Capital Advisors, Ltd. LLC Portfolio

Follow Capital Advisors, Ltd. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.